Compile Data Set for Download or QSAR
maximum 50k data
Found 21 Enz. Inhib. hit(s) with all data for entry = 6554
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139032(US8884017, 68)
Affinity DataKi:  2nM ΔG°:  -46.2kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139033(US8884017, 73)
Affinity DataKi:  2.80nM ΔG°:  -45.4kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139027(US8884017, 58)
Affinity DataKi:  3.10nM ΔG°:  -45.1kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139020(US8884017, 35)
Affinity DataKi:  3.70nM ΔG°:  -44.7kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139026(US8884017, 51)
Affinity DataKi:  3.90nM ΔG°:  -44.6kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139035(US8884017, 76)
Affinity DataKi:  6.70nM ΔG°:  -43.4kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139036(US8884017, 77)
Affinity DataKi:  20nM ΔG°:  -40.8kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139030(US8884017, 64)
Affinity DataKi:  20nM ΔG°:  -40.8kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139028(US8884017, 59)
Affinity DataKi:  20nM ΔG°:  -40.8kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139034(US8884017, 74)
Affinity DataKi:  22nM ΔG°:  -40.6kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139039(US8884017, 88)
Affinity DataKi:  28nM ΔG°:  -40.1kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139038(US8884017, 80)
Affinity DataKi:  31nM ΔG°:  -39.8kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139023(US8884017, 42)
Affinity DataKi:  37nM ΔG°:  -39.4kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139019(US8884017, 19)
Affinity DataKi:  42nM ΔG°:  -39.1kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139029(US8884017, 62)
Affinity DataKi:  50nM ΔG°:  -38.7kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139031(US8884017, 65)
Affinity DataKi:  55nM ΔG°:  -38.5kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139024(US8884017, 46)
Affinity DataKi:  58nM ΔG°:  -38.4kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139021(US8884017, 36)
Affinity DataKi:  63nM ΔG°:  -38.2kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139025(US8884017, 48)
Affinity DataKi:  75nM ΔG°:  -37.8kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139037(US8884017, 78)
Affinity DataKi:  80nM ΔG°:  -37.7kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNeuronal acetylcholine receptor subunit alpha-7(Homo sapiens (Human))
Bayer Intellectual Property

US Patent
LigandPNGBDBM139022(US8884017, 37)
Affinity DataKi:  80nM ΔG°:  -37.7kJ/molepH: 7.4 T: 2°CAssay Description:The [3H]-methyllycaconitine binding assay is a modification of the method described by Davies et al. in Neuropharmacol. 1999, 38, 679-690.Rat brain t...More data for this Ligand-Target Pair
In DepthDetails US Patent